Year 5 & Year 6 Executive Summary Report
The HIRN Year 5 & Year 6 Executive Summary Report is now available online! The report reflects significant HIRN breakthroughs, developments and advancements across the entire network. This 2-year report reflects activity from October 2018 through September 2020.
Cover Image: Dan Huh, Univ. Pennsylvania, CHIB Stanger UG3. A cross-sectional view of a vascularized three-dimensional biomimetic device visualized by scanning electron microscopy. A micro-capillary is seen in cross-section along with a functional pericyte (upper right) and surrounding matrix.
HIRN 2022 Trainee Scholarship Recipients
The following are recipients of HIRN 2022 Trainee Scholarships. These trainees submitted abstracts that were competitively reviewed by members of the HIRN Annual Meeting Planning Committee and selected as being highly meritorious.
– Gregory Golden, PhD, Postdoctoral Researcher, University of Pennsylvania
– Abhishek Kulkarni, PhD, Postdoctoral Research Fellow, University of Florida
– Olha Melnyk, PhD, Postdoctoral Research Fellow, Indiana University School of Medicine
– Ali Shilleh, Graduate Student, University of Colorado Anschutz Medical Campus
HIRN 2022 Poster Award Recipients
The following trainees were selected as award recipients based on the posters they presented at the HIRN 2022 Annual Investigator Meeting.
– Vrushali Agashe, PhD, Postdoctoral Research Scientist Columbia University Irving Medical Center
– Cristiane dos Santos, PhD, Postdoctoral Research Scientist, Vanderbilt University
– Udi Ehud Knebel, Doctoral Student, The Hebrew University of Jerusalem
– Leslie Wagner, Doctoral Student, Indiana University School of Medicine
HUMAN ISLET RESEARCH NETWORK MISSION
To better understand how human beta cells are lost in Type 1 Diabetes and to find innovative strategies to protect or replace functional beta cell mass in diabetic patients.
Click HERE to access the YouTube video of the recording. Thursday, November 10, 2022 (2:00 PM Eastern | 11:00 AM Pacific) Presentations by: Marcela Brissova, PhD, Vanderbilt University…Read More
This Funding Opportunity Announcement (FOA) invites applications to develop a centralized resource of the human pancreas for diabetes research that will provide access to deeply curated high-quality datasets, knowledge in…Read More
Independent Research Initiatives
CBDS is using human pancreatic tissues to discover mechanisms of cellular stress or dysfunction that may contribute to the development of autoimmunity in at-risk individuals, to identify specific biomarkers of the asymptomatic phase of T1D, and to develop innovative strategies to stop beta cell destruction early in the disease process.
CHIB is combining advances in beta cell biology and stem cell biology with tissue engineering technologies to develop microdevices that support functional human islets.
The CMAI is developing innovative approaches to model basic aspects of human T1D immunobiology using novel in vivo and in vitro platforms.
CTAR is investigating methods to increase or maintain functional beta cell mass in T1D through targeted manipulation of islet plasticity or engineered protection of beta cells from immune-mediated destruction.
The Human Pancreas Analysis Consortium (HPAC) is investigating the physical and functional organization of the human islet tissue environment, the cell-cell relationships within the pancreatic tissue ecosystem, and the contributions of non-endocrine components (acinar, ductal, vascular, perivascular, neuronal, lymphatic, immune) to islet cell function and dysfunction.
Opportunity Pool Projects
The Human Islet Research Network (HIRN) was established In 2014 to help organize and support collaborative research related to the loss of functional beta cell mass in Type 1 Diabetes (T1D). The project consists of five independent research initiatives.